Clinical trial
Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose…
NCT00287456 · University of Texas Southwestern Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00287456 |
|---|---|
| Title | Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients. |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Cystic Fibrosis Related Diabetes |
| Intervention type | Device, Drug, Procedure |
| Interventions | Insulin Pump, Insulin, Oral Glucose Tolerance Test, Whole body Protein Turnover |
| Enrollment | 0 |
| Start date | Feb 2, 2006 |
| Primary completion | Feb 2, 2006 |
| Completion | Feb 2, 2006 |
| First posted | Feb 6, 2006 |
| Last update posted | Jan 10, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: